Solensky Gerald JR 4
4 · Zomedica Pharmaceuticals Corp. · Filed Oct 12, 2018
Insider Transaction Report
Form 4
Solensky Gerald JR
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common Shares, without par value
2018-10-11$1.20/sh+200,000$240,000→ 38,151,100 total - Exercise/Conversion
Stock Option (right to buy)
2018-10-11−200,000→ 0 totalExercise: $1.20From: 2016-12-21Exp: 2018-12-21→ Common Shares, without par value (200,000 underlying)
Footnotes (1)
- [F1]The options vested upon grant.